DANIELLE OSTROWSKI: Open Payments
NPI 1770074536 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 17 payments from 7 companies in 2025. Trend: 2023 $140 · 2024 $488 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $124 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 3 | $52 |
| ABBVIE INC. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Ozempic, MOUNJARO, Wegovy, QULIPTA, AIRSUPRA, Rybelsus, GARDASIL 9, OTEZLA.
Industry payments across FL — which companies pay providers there.
